ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.74B
Enterprise Value 31.7B
Trailing P/E 4.43
Forward P/E 1-10.89
PEG Ratio (5 yr expected) 1-0.30
Price/Sales (ttm)3.36
Price/Book (mrq)2.20
Enterprise Value/Revenue 32.08
Enterprise Value/EBITDA 62.70

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 76.19%
Operating Margin (ttm)76.51%

Management Effectiveness

Return on Assets (ttm)38.78%
Return on Equity (ttm)68.14%

Income Statement

Revenue (ttm)817.27M
Revenue Per Share (ttm)16.54
Quarterly Revenue Growth (yoy)45,544.30%
Gross Profit (ttm)-97.06M
EBITDA 628.84M
Net Income Avi to Common (ttm)622.7M
Diluted EPS (ttm)12.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.1B
Total Cash Per Share (mrq)22.28
Total Debt (mrq)58.15M
Total Debt/Equity (mrq)4.68
Current Ratio (mrq)35.51
Book Value Per Share (mrq)25.09

Cash Flow Statement

Operating Cash Flow (ttm)635.22M
Levered Free Cash Flow (ttm)406.34M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 315.57%
S&P500 52-Week Change 34.25%
52 Week High 359.13
52 Week Low 331.97
50-Day Moving Average 352.81
200-Day Moving Average 346.69

Share Statistics

Avg Vol (3 month) 3523.7k
Avg Vol (10 day) 3562.38k
Shares Outstanding 549.57M
Float 46.27M
% Held by Insiders 10.16%
% Held by Institutions 185.23%
Shares Short (May 31, 2019) 43.85M
Short Ratio (May 31, 2019) 46.27
Short % of Float (May 31, 2019) 47.77%
Short % of Shares Outstanding (May 31, 2019) 47.76%
Shares Short (prior month Apr 30, 2019) 43.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jun 19, 2017